CTRI/2023/05/052262
Not yet recruiting
Phase 1
A Pre-clinical and clinical study to evaluate the effect of Suvarnaprashan yoga on growth and development in Children
RGGPG Ayurvedic College0 sites0 target enrollmentTBD
Overview
- Phase
- Phase 1
- Intervention
- Not specified
- Conditions
- Not specified
- Sponsor
- RGGPG Ayurvedic College
- Status
- Not yet recruiting
- Last Updated
- 2 years ago
Overview
Brief Summary
No summary available.
Investigators
Eligibility Criteria
Inclusion Criteria
- •1\)Apparently Healthy children of age upto 2 years, irrespective of gender, religion, and socio\-economic status etc.
- •2\)Parents of study subjects willing to participate in the trial.
Exclusion Criteria
- •1\.Children above two years of age.
- •2\.Children with any congenital disorder, syndrome etc.
- •3\.Neonatal Anaemia, HIV and HbsAg \+ newborn.
- •4\.Children with acute illness.
- •5\.Children who are malnourished will be excluded.
- •6\.Parents of the study subjects not willing to participate in the trial.
Outcomes
Primary Outcomes
Not specified
Similar Trials
Completed
Phase 1
An Experimental and clinical trial to study the effect of Triphala RasayanaCTRI/2020/07/026483RGGPG Ayurvedic College and Hospital Paprola28
Not yet recruiting
Not Applicable
To study the efficacy ofAshwagandhadi Avaleha as an Adjuvant with Anti Tubercular Treatment.Health Condition 1: J989- Respiratory disorder, unspecifiedCTRI/2021/05/033863Principal
Completed
Phase 3
Efficacy of Arjuna Ksheerapaka Churna for managing high lipid level in the bodyCTRI/2020/06/026173RGGPG Ayurvedic College30
Not yet recruiting
Not Applicable
Efficacy of Neelkanthi churna in Madhumeha w.s.r to Type 2 Diabetes MellitusHealth Condition 1: E119- Type 2 diabetes mellitus without complicationsCTRI/2021/06/034030Principal
Not yet recruiting
Not Applicable
A study conducted in outside human body to evaluate the Efficacy of a type of Cells Manufactured from Healthy Volunteers and Patients with Relapsed/ Refractory Acute Lymphoblastic Leukemia (a type of blood cancer) in laboratory settingHealth Condition 1: null- Pediatric patients with relapsed blood cancerCTRI/2016/12/007517TMC Research Administration Council20